80
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Safety of high-dose daptomycin in patients with severe renal impairment

, , , &
Pages 493-499 | Published online: 13 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (11)

Chunyan Wei, Wanhong Yin, Zhiyao He & Bin Wu. (2023) Reporting of Drug-Induced Myopathies Associated with the Combination of Statins and Daptomycin: A Disproportionality Analysis Using the US Food and Drug Administration Adverse Event Reporting System. Journal of Clinical Medicine 12:10, pages 3548.
Crossref
Rami H. Jaber & Nathan P. Beahm. (2023) Daptomycin for the treatment of acute bacterial meningitis: A narrative review. International Journal of Antimicrobial Agents 61:5, pages 106770.
Crossref
Lingling Ye, Xiang You, Jie Zhou, Chaohui Wu, Meng Ke, Wanhong Wu, Pinfang Huang & Cuihong Lin. (2022) Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment. Frontiers in Pharmacology 13.
Crossref
Hideo Kato, Mao Hagihara, Mariko Kato, Yuka Yamagishi, Takumi Umemura, Nobuhiro Asai, Jun Hirai, Takuya Iwamoto & Hiroshige Mikamo. (2022) A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients. Antibiotics 11:6, pages 710.
Crossref
Masaru Samura, Keisuke Takada, Naoki Hirose, Takenori Kurata, Fumio Nagumo, Sakura Koshioka, Junichi Ishii, Masaki Uchida, Junki Inoue, Yuki Enoki, Kazuaki Taguchi, Koji Tanikawa & Kazuaki Matsumoto. (2022) Incidence of elevated creatine phosphokinase between daptomycin alone and concomitant daptomycin and statins: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology 88:5, pages 1985-1998.
Crossref
Timothy W. Jones, Ah Hyun Jun, Jessica L. Michal & William J. Olney. (2021) High-Dose Daptomycin and Clinical Applications. Annals of Pharmacotherapy 55:11, pages 1363-1378.
Crossref
Tomoyuki Yamada, Satoru Mitsuboshi, Kaoru Suzuki, Masami Nishihara & Kazuhisa Uchiyama. (2021) Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database. Basic & Clinical Pharmacology & Toxicology 129:3, pages 268-272.
Crossref
Olga O. Vlashyn, Ashley M. Lorenz, Mohammad M. Sobhanie, Jessica M. Smith, Megan Bond & Lynn Wardlow. (2020) Safety outcomes with high‐dose daptomycin in patients with acute kidney injury and/or end‐stage renal disease. Journal of Clinical Pharmacy and Therapeutics 46:2, pages 363-368.
Crossref
Chien‐Chih Wu, Fang‐Ju Lin, Shu‐Wen Lin, Yunn‐Fang Ho, Chih‐Fen Huang, Li‐Jiuan Shen & Fe‐Lin Lin Wu. (2020) Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 3:5, pages 959-965.
Crossref
Romain Bricca, Sylvain Goutelle, Sandrine Roux, Marie-Claude Gagnieu, Agathe Becker, Anne Conrad, Florent Valour, Frederic Laurent, Claire Triffault-Fillit, Christian Chidiac, Tristan Ferry, Tristan Ferry, Florent Valour, Thomas Perpoint, André Boibieux, François Biron, Patrick Miailhes, Florence Ader, Agathe Becker, Sandrine Roux, Claire Triffault-Fillit, Anne Conrad, Alexie Bosch, Fatiha Daoud, Johanna Lippman, Evelyne Braun, Christian Chidiac, Sébastien Lustig, Elvire Servien, Romain Gaillard, Antoine Schneider, Stanislas Gunst, Cécile Batailler, Michel-Henry Fessy, Yannick Herry, Anthony Viste, Philippe Chaudier, Cyril Courtin, Lucie Louboutin, Sébastien Martres, Franck Trouillet, Cédric Barrey, Emmanuel Jouanneau, Timothée Jacquesson, Ali Mojallal, Fabienne Braye, Fabien Boucher, Hristo Shipkov, Joseph Chateau, Philippe Céruse, Carine Fuchsmann, Arnaud Gleizal, Frédéric Aubrun, Mikhail Dziadzko, Caroline Macabéo, Frederic Laurent, Jean-Philippe Rasigade, Laetitia Beraut, Céline Dupieux, Camille Kolenda, Jérôme Josse, Fabien Craighero, Loic Boussel, Jean-Baptiste Pialat, Isabelle Morelec, Marc Janier, Francesco Giammarile, Michel Tod, Marie-Claude Gagnieu, Sylvain Goutelle & Eugénie Mabrut. (2019) Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection . Journal of Antimicrobial Chemotherapy 74:4, pages 1012-1020.
Crossref
A. Bitar De Zayas-Enriquez & C. Soper. (2019) Daptomycin-Induced Posterior Reversible Encephalopathy Syndrome (PRES). Case Reports in Neurological Medicine 2019, pages 1-4.
Crossref